Literature DB >> 2050275

Origin of the high constitutive level of progesterone receptor in T47-D breast cancer cells.

J F Savouret1, F Fridlanski, M Atger, M Misrahi, R Berger, E Milgrom.   

Abstract

The T47-D breast cancer cell line constitutively expresses high levels of progesterone receptor (PR). This does not appear to be related to an anomaly in the estrogen receptor (ER) as shown by cloning of the ER cDNA from T47-D cells and its insertion into the expression vector pKSV-10. When transfected into heterologous Cos-7 and L cells this receptor exerts a normal biological activity, stimulating the transcription of a reporter gene only in the presence of estrogen. Moreover, normal estrogen regulation of the transcription of the reporter gene was also observed in situ in T47-D cells. Southern blot experiments showed the presence of four copies of the progesterone receptor gene in T47-D cells. This was related to the existence of four copies of chromosome 11 in these cells. The most likely explanation of the anomalous regulation of progesterone receptor expression in T47-D cells is thus the presence of at least one copy of the PR gene bearing an anomaly in its regulatory region(s).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2050275     DOI: 10.1016/0303-7207(91)90230-p

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  7 in total

1.  Sex hormone-dependent regulation of cilia beat frequency in airway epithelium.

Authors:  Raksha Jain; Jennifer M Ray; Jie-hong Pan; Steven L Brody
Journal:  Am J Respir Cell Mol Biol       Date:  2011-10-27       Impact factor: 6.914

2.  Estrogen receptor alpha-negative and progesterone receptor-positive breast cancer: lab error or real entity?

Authors:  Jawad Kiani; Afrasyab Khan; Hina Khawar; Fawad Shuaib; Shahid Pervez
Journal:  Pathol Oncol Res       Date:  2006-12-25       Impact factor: 3.201

3.  Progesterone receptor (PR) polyproline domain (PPD) mediates inhibition of epidermal growth factor receptor (EGFR) signaling in non-small cell lung cancer cells.

Authors:  Sornsawan Kawprasertsri; Richard J Pietras; Diana C Marquez-Garban; Viroj Boonyaratanakornkit
Journal:  Cancer Lett       Date:  2016-02-15       Impact factor: 8.679

4.  Characterization of the hormone responsive element involved in the regulation of the progesterone receptor gene.

Authors:  J F Savouret; A Bailly; M Misrahi; C Rauch; G Redeuilh; A Chauchereau; E Milgrom
Journal:  EMBO J       Date:  1991-07       Impact factor: 11.598

5.  Nucleocytoplasmic shuttling of the progesterone receptor.

Authors:  A Guiochon-Mantel; P Lescop; S Christin-Maitre; H Loosfelt; M Perrot-Applanat; E Milgrom
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

6.  Changes in epidermal growth factor receptor expression and response to ligand associated with acquired tamoxifen resistance or oestrogen independence in the ZR-75-1 human breast cancer cell line.

Authors:  B Long; B M McKibben; M Lynch; H W van den Berg
Journal:  Br J Cancer       Date:  1992-06       Impact factor: 7.640

7.  Oestrogen receptor negative-progesterone receptor positive phenotype in 1,211 breast tumours.

Authors:  M F Pichon; E Milgrom
Journal:  Br J Cancer       Date:  1992-06       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.